BioCentury | Nov 25, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...to discover small molecules that modulate protein-protein interactions. NovAliX will generate lead candidates using its Graffinity...
BioCentury | Mar 18, 2013
Strategy

Japan's biggest biotech

...and royalties on antibodies licensed by Kyowa Discovery/Preclin Jan-13 NovAliX S.A.S. Research collaboration Use NovAliX's Graffinity...
BioCentury | Jan 21, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...NovAliX partnered with Kyowa to use NovAliX's Graffinity fragment-based screening technology to discover and develop small...
BioCentury | Jan 15, 2013
Company News

NovAliX, Kyowa in discovery deal

...NovAliX S.A.S. (Illkirch, France) partnered with Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) to use NovAliX's Graffinity...
BioCentury | Oct 15, 2012
Company News

NovAliX, Servier deal

...Servier announced a deal with NovAliX to use NovAliX's Graffinity fragment-based screening technology to discover small...
BioCentury | Oct 10, 2012
Company News

NovAliX, Servier in discovery deal

...Servier (Neuilly-sur-Seine, France) announced a deal with NovAliX S.A.S. (Illkirch, France) to use NovaAliX's Graffinity fragment-based...
BioCentury | Sep 5, 2011
Company News

Galapagos, NovAliX deal

...NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its Graffinity fragment-based screening technology to discover and develop small molecule...
BioCentury | Apr 4, 2011
Company News

NovAliX S.A.S., Shionogi deal

...NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its SPR imaging screening technology to discover small molecule compounds against...
...SPR imaging screening technology to discover small molecule compounds against an undisclosed target from Shionogi. Graffinity...
BioCentury | Nov 22, 2010
Company News

Graffinity, NovAliX deal

...NovAliX acquired a majority stake in fragment-based drug discovery services company Graffinity. NovAliX said Graffinity's small...
...NovAliX's x-ray crystallography, supramolecular mass spectrometry and liquid-/solid-state NMR services. Further terms were not disclosed. Graffinity Pharmaceuticals GmbH...
BioCentury | Oct 19, 2009
Company News

Graffinity, Roche deal

...screening technology to generate small molecule hits against undisclosed targets for Roche's Genentech Inc. unit. Graffinity...
...technology access fees and is eligible for chemistry services payments. Further terms were not disclosed. Graffinity Pharmaceuticals GmbH...
Items per page:
1 - 10 of 68
BioCentury | Nov 25, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...to discover small molecules that modulate protein-protein interactions. NovAliX will generate lead candidates using its Graffinity...
BioCentury | Mar 18, 2013
Strategy

Japan's biggest biotech

...and royalties on antibodies licensed by Kyowa Discovery/Preclin Jan-13 NovAliX S.A.S. Research collaboration Use NovAliX's Graffinity...
BioCentury | Jan 21, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...NovAliX partnered with Kyowa to use NovAliX's Graffinity fragment-based screening technology to discover and develop small...
BioCentury | Jan 15, 2013
Company News

NovAliX, Kyowa in discovery deal

...NovAliX S.A.S. (Illkirch, France) partnered with Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) to use NovAliX's Graffinity...
BioCentury | Oct 15, 2012
Company News

NovAliX, Servier deal

...Servier announced a deal with NovAliX to use NovAliX's Graffinity fragment-based screening technology to discover small...
BioCentury | Oct 10, 2012
Company News

NovAliX, Servier in discovery deal

...Servier (Neuilly-sur-Seine, France) announced a deal with NovAliX S.A.S. (Illkirch, France) to use NovaAliX's Graffinity fragment-based...
BioCentury | Sep 5, 2011
Company News

Galapagos, NovAliX deal

...NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its Graffinity fragment-based screening technology to discover and develop small molecule...
BioCentury | Apr 4, 2011
Company News

NovAliX S.A.S., Shionogi deal

...NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its SPR imaging screening technology to discover small molecule compounds against...
...SPR imaging screening technology to discover small molecule compounds against an undisclosed target from Shionogi. Graffinity...
BioCentury | Nov 22, 2010
Company News

Graffinity, NovAliX deal

...NovAliX acquired a majority stake in fragment-based drug discovery services company Graffinity. NovAliX said Graffinity's small...
...NovAliX's x-ray crystallography, supramolecular mass spectrometry and liquid-/solid-state NMR services. Further terms were not disclosed. Graffinity Pharmaceuticals GmbH...
BioCentury | Oct 19, 2009
Company News

Graffinity, Roche deal

...screening technology to generate small molecule hits against undisclosed targets for Roche's Genentech Inc. unit. Graffinity...
...technology access fees and is eligible for chemistry services payments. Further terms were not disclosed. Graffinity Pharmaceuticals GmbH...
Items per page:
1 - 10 of 68